AVAC relaunches Weekly NewsDigest: A compilation of media coverage, published research, policy news and materials on HIV prevention options
- View the current edition (Volume 11, Number 2)
Announcing the release of the new Px Wire, AVAC’s quarterly update on HIV prevention research. Highlights include:
- The results from MDP
301, a trial of the microbicide PRO
2000
- CDC’s newly modified
PrEP trial (TDF2
in Botswana)
- The evolving effort to understand the Thai prime-boost AIDS vaccine results;
- Recent NIH grants on rectal microbicides; and
- Timeline of 2010 trial milestones
Recent Advocates Calls
- Epidemiology
of HIV Among MSM in Africa: Implications for
rectal microbicides - AVAC and IRMA,
January 27th,
2009
- Advocates' briefing on results from the PRO 2000 microbicide MDP 301 study - Global Campaign for Microbicides, December 15, 2009.
- Efficacy and Effectiveness - What is Good Enough? Who decides? - AVAC, Global Campaign for Microbicides and IRMA, December 4, 2009
- Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions - Research Working Group of the PrEP Committee, December 9, 2009
- Visit our meeting reports page to listen to other Advocates' Calls
Documentary Series "Creating Solutions" features AIDS vaccine research